Literature DB >> 15081669

Interstitial lung disease and disease modifying anti-rheumatic drugs.

David L Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15081669     DOI： 10.1016/S0140-6736(04)15969-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy.

Authors:  Alexander Rozin; Mordechai Yigla; Luda Guralnik; Zohar Keidar; Euvgeni Vlodavsky; Michael Rozenbaum; Abraham Menahem Nahir; Alexandra Balbir-Gurman
Journal:  Clin Rheumatol       Date:  2005-10-07       Impact factor: 2.980

Review 2.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.